<p><em>重新分類降低了研究的障礙，並消除了懲罰性的 280E 税負</em></p>
<p>, /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (&#34;Trulieve&#34;或&#34;公司&#34;), 是美國領先且表現優異的 cannabis 公司，讚揚特朗普政府採取的將大麻重新分類為《受控物質法》第三類的行動。</p>
<p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/1720011/Trulieve_LogoV1.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/1720011/Trulieve_LogoV1.jpg"/></p>
<p>&#34;特朗普總統的這一大膽且歷史性的方向代表了長期以來的變革，是大麻改革的重要里程碑，&#34; Trulieve 首席執行官 Kim Rivers 表示。&#34;Trulieve 對政府採取的果斷行動表示感謝，這一行動承認了大麻的醫療益處，支持持牌和受監管的運營商，並允許執法機構起訴不法行為者。我們致力於在整個過程中支持政府。&#34;</p>
<p>將大麻重新分類為第三類並不意味着大麻合法化，但這是實現切實可行的大麻改革的重要第一步。將大麻移至第三類為更深入的醫療大麻研究打開了大門，消除了《税法》第 280E 條款施加的懲罰性税負，併為執法機構保留了針對和懲罰非法運營商的靈活性。</p>
<p><strong>降低進行關鍵醫療大麻研究的障礙</strong> 將大麻重新分類為第三類承認了大麻的醫療益處，並降低了在美國進行醫療研究的限制。近年來，關於大麻特性和益處的前沿研究主要在其他國家進行，這些國家對研究的限制較少。隨着這一變化，美國公司和大學可以在研究醫療應用以及適當劑量和形式方面領先，包括針對退伍軍人和老年人的不同患者羣體。</p>
<p><strong>消除對州合法大麻運營商施加的懲罰性 280E 税負</strong>《税法》第 280E 條款的實施是為了禁止銷售第一類或第二類物質的毒販對普通商業費用進行税收扣除。第 280E 條款的採用早於州合法大麻項目，因此並未明確區分外國販毒集團等毒販與受州監管機構嚴格監督的持牌運營商。根據定義，第 280E 條款不適用於第三類物質。消除 280E 税負有效支持提供經過測試、標記和年齡限制的大麻產品的州合法運營商。</p>
<p><strong>與更廣泛的承諾一致，打擊非法運營商和外國販毒集團</strong> 重新分類大麻為大麻改革帶來了常識，承認了大麻與海洛因和合成芬太尼等危險藥物之間的區別。重新分類並不意味着大麻合法化。執法機構保留了積極打擊非法運營商、保護我們的社區免受非法藥物跨境流入的權力，並起訴向兒童銷售大麻的不法行為者。</p>
<p><strong>關於 Trulieve</strong> Trulieve 是一家行業領先的垂直整合大麻公司和美國多州運營商，在亞利桑那州、佛羅里達州和賓夕法尼亞州擁有領先的市場地位。Trulieve 準備加速增長和擴展，通過其中心戰略在新市場和現有市場中建立零售和分銷規模。通過提供創新的高質量產品，Trulieve 在其品牌組合中提供最佳客户體驗，並增加對大麻的獲取，幫助患者和客户無障礙生活。Trulieve 在 CSE 上市，股票代碼為 TRUL，並在 OTCQX 市場交易，股票代碼為 TCNNF。有關更多信息，請訪問 Trulieve.com。</p>
<p>Facebook: @Trulieve</p>
<p>Instagram: @Trulieve</p>
<p>X: @Trulieve</p>
<p><strong>投資者和媒體聯繫</strong> Christine Hersey，投資者關係副總裁</p>
<p>+1 (424) 202-0210</p>
<p>Christine.Hersey@Trulieve.com</p>
<p>來源 Trulieve Cannabis Corp.</p>

TCNNF

<p>Trulieve Cannabis Corp. 對特朗普政府決定將大麻重新分類為《受控物質法》下的第三類物質表示讚賞。此舉減輕了研究障礙，消除了懲罰性的 280E 税負，並支持執法部門打擊非法經營者。Trulieve 首席執行官 Kim Rivers 強調了這一變化對大麻改革的重要性以及大麻的醫療益處。重新分類允許進行更深入的醫學研究，並支持合法州的大麻經營者</p>

<p><em>Reclassification Eases Barriers to Research and Removes Punitive 280E Tax Burden</em></p>
<div class="lb-trans"><p><em>重新分類降低了研究的障礙，並消除了懲罰性的 280E 税負</em></p>
</div><p>, /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (&#34;Trulieve&#34; or &#34;the Company&#34;), a leading and top-performing cannabis company in the U.S., applauds action taken by the Trump Administration to reclassify marijuana to Schedule III under the Controlled Substances Act.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (&#34;Trulieve&#34;或&#34;公司&#34;), 是美國領先且表現優異的 cannabis 公司，讚揚特朗普政府採取的將大麻重新分類為《受控物質法》第三類的行動。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/1720011/Trulieve_LogoV1.jpg" alt="" original-src="https://mma.prnewswire.com/media/1720011/Trulieve_LogoV1.jpg"/></p>
<p>&#34;This bold and historic direction from President Trump represents long overdue change and a major milestone in cannabis reform,&#34; said Trulieve Chief Executive Officer Kim Rivers. &#34;Trulieve is grateful for the decisive action taken by the Administration that acknowledges the medical benefits of cannabis, supports licensed and regulated operators, and allows law enforcement agencies to prosecute bad actors. We are committed to supporting the Administration throughout this process.&#34;</p>
<div class="lb-trans"><p>&#34;特朗普總統的這一大膽且歷史性的方向代表了長期以來的變革，是大麻改革的重要里程碑，&#34; Trulieve 首席執行官 Kim Rivers 表示。&#34;Trulieve 對政府採取的果斷行動表示感謝，這一行動承認了大麻的醫療益處，支持持牌和受監管的運營商，並允許執法機構起訴不法行為者。我們致力於在整個過程中支持政府。&#34;</p>
</div><p>Reclassification of marijuana to Schedule III does not legalize marijuana but it is an important first step in achieving practical common sense cannabis reform. Moving marijuana to Schedule III opens the door for more robust research of medical marijuana, removes the punitive tax burden imposed by Section 280E of the tax code, and retains flexibility for law enforcement to target and punish illicit operators.</p>
<div class="lb-trans"><p>將大麻重新分類為第三類並不意味着大麻合法化，但這是實現切實可行的大麻改革的重要第一步。將大麻移至第三類為更深入的醫療大麻研究打開了大門，消除了《税法》第 280E 條款施加的懲罰性税負，併為執法機構保留了針對和懲罰非法運營商的靈活性。</p>
</div><p><strong>Eases Barriers to Conducting Critical Medical Marijuana Research</strong> Reclassifying marijuana to Schedule III acknowledges the medical benefits of marijuana and eases restrictions on conducting medical research in the U.S. In recent years, cutting edge research on the properties and benefits of marijuana has primarily been conducted in other countries with fewer restrictions on research. With this change, American companies and universities can take the lead with research designed to delineate medical applications as well as appropriate dosages and form factors for various patient populations including veterans and seniors.</p>
<div class="lb-trans"><p><strong>降低進行關鍵醫療大麻研究的障礙</strong> 將大麻重新分類為第三類承認了大麻的醫療益處，並降低了在美國進行醫療研究的限制。近年來，關於大麻特性和益處的前沿研究主要在其他國家進行，這些國家對研究的限制較少。隨着這一變化，美國公司和大學可以在研究醫療應用以及適當劑量和形式方面領先，包括針對退伍軍人和老年人的不同患者羣體。</p>
</div><p><strong>Removes Punitive 280E Tax Burden Imposed on State Legal Cannabis Operators</strong> Section 280E of the tax code was implemented to prohibit drug traffickers selling Schedule I or Schedule II substances from taking tax deductions for ordinary business expenses. The adoption of Section 280E preceded state legal marijuana programs and thus did not explicitly differentiate between drug traffickers such as foreign cartels and licensed operators subject to strict oversight by state regulators. By definition, Section 280E does not apply to Schedule III substances. Removing the 280E tax burden effectively supports state legal operators who provide patients and adults tested, labeled, and age-gated cannabis products.</p>
<div class="lb-trans"><p><strong>消除對州合法大麻運營商施加的懲罰性 280E 税負</strong>《税法》第 280E 條款的實施是為了禁止銷售第一類或第二類物質的毒販對普通商業費用進行税收扣除。第 280E 條款的採用早於州合法大麻項目，因此並未明確區分外國販毒集團等毒販與受州監管機構嚴格監督的持牌運營商。根據定義，第 280E 條款不適用於第三類物質。消除 280E 税負有效支持提供經過測試、標記和年齡限制的大麻產品的州合法運營商。</p>
</div><p><strong>Aligns With Broader Commitment to Stopping Illegal Operators and Foreign Cartels</strong> Rescheduling marijuana applies common sense to cannabis reform by recognizing the difference between marijuana and dangerous drugs such as heroin and synthetic fentanyl. Rescheduling does not legalize marijuana. Law enforcement agencies retain the authority to aggressively target illicit operators, protect our communities from illegal drugs crossing our borders, and prosecute bad actors selling marijuana to children.</p>
<div class="lb-trans"><p><strong>與更廣泛的承諾一致，打擊非法運營商和外國販毒集團</strong> 重新分類大麻為大麻改革帶來了常識，承認了大麻與海洛因和合成芬太尼等危險藥物之間的區別。重新分類並不意味着大麻合法化。執法機構保留了積極打擊非法運營商、保護我們的社區免受非法藥物跨境流入的權力，並起訴向兒童銷售大麻的不法行為者。</p>
</div><p><strong>About Trulieve</strong> Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.</p>
<div class="lb-trans"><p><strong>關於 Trulieve</strong> Trulieve 是一家行業領先的垂直整合大麻公司和美國多州運營商，在亞利桑那州、佛羅里達州和賓夕法尼亞州擁有領先的市場地位。Trulieve 準備加速增長和擴展，通過其中心戰略在新市場和現有市場中建立零售和分銷規模。通過提供創新的高質量產品，Trulieve 在其品牌組合中提供最佳客户體驗，並增加對大麻的獲取，幫助患者和客户無障礙生活。Trulieve 在 CSE 上市，股票代碼為 TRUL，並在 OTCQX 市場交易，股票代碼為 TCNNF。有關更多信息，請訪問 Trulieve.com。</p>
</div><p>Facebook: @Trulieve</p>
<div class="lb-trans"><p>Facebook: @Trulieve</p>
</div><p>Instagram: @Trulieve</p>
<div class="lb-trans"><p>Instagram: @Trulieve</p>
</div><p>X: @Trulieve</p>
<div class="lb-trans"><p>X: @Trulieve</p>
</div><p><strong>Investor and Media Contact</strong> Christine Hersey, Vice President of Investor Relations</p>
<div class="lb-trans"><p><strong>投資者和媒體聯繫</strong> Christine Hersey，投資者關係副總裁</p>
</div><p>+1 (424) 202-0210</p>
<div class="lb-trans"><p>+1 (424) 202-0210</p>
</div><p>Christine.Hersey@Trulieve.com</p>
<div class="lb-trans"><p>Christine.Hersey@Trulieve.com</p>
</div><p>SOURCE Trulieve Cannabis Corp.</p>
<div class="lb-trans"><p>來源 Trulieve Cannabis Corp.</p>
</div>

Trulieve 讚揚特朗普政府將大麻重新分類為附表 III 的決定 | TCNNF 股票新聞